Head-to-head · WeighScore
RxSpan MD vs Superior Remedies
The verdict
RxSpan MD takes it — 86.8/100 to 57.5/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | RxSpan MD | Superior Remedies |
|---|---|---|
| WeighScore | 86.8/100 | 57.5/100 |
| Grade | B | C |
| Scorecard rank | #4 | #404 |
| Semaglutide | From $194/mo | Not disclosed |
| Tirzepatide | $329/mo | Not disclosed |
| Coverage | All 50 states | All 50 states (telehealth nationwide) |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #4 · B
Strengths
- Available in all 50 states
- Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
- Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
- Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching
Where it loses points
- Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
- Published pricing is for the compounded line — brand-name pricing isn’t itemized
- A prescription isn’t guaranteed — a provider reviews eligibility after checkout
Graded #404 · C
Strengths
- Runs a dedicated GLP-1 Microdose program with its own page, framed for metabolic health and body composition rather than aggressive weight loss
- Publishes a clinical exclusion that turns business away: patients with significant weight to lose are told they would be better served by a standard GLP-1 protocol
- Charges nothing if you are not approved, and states telehealth availability in all 50 states
- Names its exclusions plainly, including medullary thyroid carcinoma or MEN 2 history and pregnancy
Where it loses points
- ⚠⚠ No price on any program page — the only public figure is a homepage headline labeled a limited-time offer and attached to the general pitch rather than to a program
- ⚠ No milligram figure anywhere, so "microdose" describes an intent rather than an amount
- No compounding pharmacy is named
- Compounded GLP-1s are not FDA-approved
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 509 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.